eFFECTOR Therapeutics, Inc. (EFTRW) Financials

EFTRW Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 20.2 million 24.1 million
2023-06-30 26.9 million 24.3 million
2023-03-31 21.9 million 26.7 million
2022-12-31 29.1 million 25.2 million

EFTRW Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -7.8 million 1.1 million
2023-06-30 -8.6 million 1.2 million
2023-03-31 -7.7 million 1.2 million
2022-12-31 -6.8 million 1.4 million

EFTRW Net Income

No data available :(

EFTRW Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 17.8 million - 77000
2023-06-30 25.0 million - 94000
2023-03-31 19.0 million - 109000
2022-12-31 26.3 million - 120000

EFTRW Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 2.5 million
2023-06-30 1.9 million
2023-03-31 1.7 million
2022-12-31 1.7 million

EFTRW Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 2000 5.4 million 2.5 million -
2023-06-30 28000 4.9 million 3.0 million -
2023-03-31 13000 6.6 million 2.9 million -
2022-12-31 13000 6.6 million 2.7 million -

EFTRW Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 26000
2023-06-30 - 27000
2023-03-31 - 28000
2022-12-31 675000 27000

EFTRW

Price: $0.03

52 week price:
0.02
0.04

Earnings Per Share: -0.91 USD

P/E Ratio: -0.12

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 3053

Market Capitalization: 23.4 million

Links: